These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4182541

  • 1. [Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone].
    Tourniaire A, Blum J, Guyot R, Madignier M.
    Sem Hop; 1969 Apr 26; 45(20):1388-92. PubMed ID: 4182541
    [No Abstract] [Full Text] [Related]

  • 2. [The problem of potassium and diuretics].
    Bernik V.
    Rev Paul Med; 1972 Sep 26; 80(3):127-32. PubMed ID: 4602416
    [No Abstract] [Full Text] [Related]

  • 3. [Electrocardiographic observations in secondary aldosteronism].
    Hilmer W.
    Med Klin; 1972 Jan 28; 67(4):128-33. PubMed ID: 5060139
    [No Abstract] [Full Text] [Related]

  • 4. [Hyperkalemias in cardiac patients].
    Raynaud R, Brochier M, Raynaud P, Fauchier JP.
    Sem Hop; 1974 Oct 08; 50(40):2463-70. PubMed ID: 4374758
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of spironolactone on the myocardial hyperexcitability of decompensated cardiopathies].
    Tourniaire A, Blum J, Guyot R, Madignier M.
    Lyon Med; 1965 Dec 05; 214(49):1219-31. PubMed ID: 5859396
    [No Abstract] [Full Text] [Related]

  • 6. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G, Klüsener W.
    Med Klin; 1981 Jan 02; 76(1):20-3. PubMed ID: 7254119
    [Abstract] [Full Text] [Related]

  • 7. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 8. [Effects of spironolactone on myocardial hyperexcitability in decompensated heart failure].
    Tourniaire A, Blum J.
    Coeur Med Interne; 1973 Apr 02; 12(1):147-52. PubMed ID: 4727375
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Classic treatment of chronic heart insufficiency. What if new?].
    Aumont MC, Agnola D, Juliard JM, Karrillon G.
    Arch Mal Coeur Vaiss; 1995 Apr 02; 88(4 Suppl):599-602. PubMed ID: 7487308
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B, Cybulski J, Chamiec T.
    Pol Merkur Lekarski; 2000 Aug 02; 9(50):519-21. PubMed ID: 11081314
    [Abstract] [Full Text] [Related]

  • 17. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr 02; 15(82):46-9. PubMed ID: 16604728
    [Abstract] [Full Text] [Related]

  • 18. Heart failure and cardiac arrhythmias.
    Fleming JS.
    Practitioner; 1974 Oct 02; 213(1276 SPEC NO):448-53. PubMed ID: 4457837
    [No Abstract] [Full Text] [Related]

  • 19. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 02; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 20. [Prevention of potassium metabolism disorders arising during the treatment of cardiac insufficiency with diuretics].
    Vinogradov AV, Matveev LN.
    Kardiologiia; 1967 May 02; 7(5):31-6. PubMed ID: 5608087
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.